Javier Benítez del Castillo Sánchez

ORCID: 0000-0003-4179-3898
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glaucoma and retinal disorders
  • Ocular Surface and Contact Lens
  • Retinal Diseases and Treatments
  • Ocular Infections and Treatments
  • Intraocular Surgery and Lenses
  • Corneal surgery and disorders
  • Corneal Surgery and Treatments
  • Allergic Rhinitis and Sensitization
  • Retinal Imaging and Analysis
  • Neurological Disorders and Treatments
  • Ophthalmology and Eye Disorders
  • Ocular Diseases and Behçet’s Syndrome
  • Urticaria and Related Conditions
  • Surgical Sutures and Adhesives
  • Optical Coherence Tomography Applications
  • Retinopathy of Prematurity Studies
  • Cerebral Venous Sinus Thrombosis
  • Retinal and Optic Conditions
  • MicroRNA in disease regulation
  • Salivary Gland Disorders and Functions
  • Dermatology and Skin Diseases
  • Machine Learning in Healthcare
  • Kawasaki Disease and Coronary Complications
  • Protein Interaction Studies and Fluorescence Analysis
  • Bee Products Chemical Analysis

Universidad de Cádiz
2017-2024

Hospital Clínico San Carlos
2011-2023

Clínica Rementería
2023

Hospital Jerez Puerta del Sur
2011-2022

Universitat de València
2022

Instituto de Salud Carlos III
2020-2022

Andalusian Health Service
2017-2018

Universidad Complutense de Madrid
2018

European Society of Anaesthesiology
2005

Instituto Ramón y Cajal de Investigación Sanitaria
1997

Background: Women, and those older than 65 years of age, are particularly susceptible to dry eye disorders (DEDs). Inflammation is clearly involved in the pathogenesis DEDs, there mounting evidence on antioxidant antiinflammatory properties essential polyunsaturated fatty acids (EPUFAs). Objective: To analyze whether a combined formulation antioxidants long-chain EPUFAs may improve evolution DEDs. Methods: We used prospective study address relationship between risk factors, clinical...

10.2147/cia.s40640 article EN cc-by-nc Clinical Interventions in Aging 2013-02-01

Objective Dry eye disease (DED) is a multifactorial involving the tears and ocular surface. It impacts patient’s quality of life (QoL) ability to perform daily activities. This study assessed burden self-reported DED among adults in eight European countries. Design Online cross-sectional survey. Setting General population France, Italy, Germany, Greece, Netherlands, Portugal, Spain Sweden. Participants Adults aged ≥18 years with (n=6084) without (n=6161) were recruited via emails screened....

10.1136/bmjopen-2022-067007 article EN cc-by-nc BMJ Open 2023-03-01

Background: The aim of this study was to assess the expression cytokines/chemokines in tears from patients with non-advanced primary open-angle glaucoma and non-severe dry eye disease versus healthy controls. Methods: This prospective, observational cohort enrolled confirmed or suspected who received any prostaglandin analogue monotherapy for longer than 6 months, disease, Expression interleukin-1β, interleukin-2, interleukin-4, interleukin-5, interleukin-6, interleukin-8, interleukin-10,...

10.1177/1120672118795399 article EN European Journal of Ophthalmology 2018-09-03

Background: Glaucoma and dry eye disorders (DEDs) are frequent comorbidities. The antioxidant anti-inflammatory properties of essential polyunsaturated fatty acids have been extensively studied in relation to diseases. Objective: Our objective was determine the effects oral supplementation with a combined formulation antioxidants on expression cytokines chemokines tears from patients DEDs or primary open-angle glaucoma (POAG). Methods: Participants (n = 97) were distributed into three...

10.2147/cia.s43191 article EN cc-by-nc Clinical Interventions in Aging 2013-06-01

Abstract: Disorders of the lacrimal functional unit are common in ophthalmological practice, with meibomian gland dysfunction, blepharitis, and dry eye forming a significant part general ophthalmologist's practice. The eyelid its associated structures form complex organ designed to protect fragile corneal surface improve visual acuity. This is subject number disorders, including syndrome, anterior allergic dermatological conditions, disorders contact lens use. Although commonly described...

10.2147/opth.s33133 article EN cc-by-nc Clinical ophthalmology 2012-10-01

A non-interventional, multicenter, European, prospective evaluation of the effectiveness, tolerability, and safety a topical preservative-free tafluprost (0.0015%) timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC) in adults with open-angle glaucoma (OAG) ocular hypertension (OHT) demonstrating insufficient response to beta-receptor blockers or prostaglandin analogue (PGA) monotherapy. Mean intraocular pressure (IOP) change from baseline was measured at study visits following...

10.1007/s12325-020-01239-8 article EN cc-by-nc Advances in Therapy 2020-02-18

Open-angle glaucoma (OAG), the most prevalent clinical type of glaucoma, is still main cause irreversible blindness worldwide. OAG a neurodegenerative illness for which important risk factor elevated intraocular pressure (IOP). Many questions remain unanswered about OAG, such as whether nutritional or toxic habits, other personal characteristics, and/or systemic diseases influence course glaucoma. As such, in this study, we performed multicenter analytical, observational, case–control study...

10.3390/jcm11195649 article EN Journal of Clinical Medicine 2022-09-25

Purpose: Data are presented from ophthalmology clinics in Spain participating the VISIONARY study, examining effectiveness, tolerability, and safety of preservative-free tafluprost (0.0015%) timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC) treatment OAG OHT. Methods: An observational, multicenter prospective study examined outcomes following a switch to PF FC adult OAG/OHT patients demonstrating insufficient response beta-blocker or prostaglandin analog (PGA) monotherapy....

10.1089/jop.2021.0099 article EN cc-by Journal of Ocular Pharmacology and Therapeutics 2022-03-01

To compare the abilities of current commercially available versions scanning laser polarimetry (SLP) and optical coherence tomography (OCT), SLP-variable corneal compensation (VCC), SLP-enhanced (ECC), high-definition (HD) OCT, in discriminating between healthy eyes those with early-to-moderate glaucomatous visual field loss.Healthy volunteers patients glaucoma who met eligibility criteria were consecutively enrolled this prospective, cross-sectional, observational study. Subjects underwent...

10.5301/ejo.2010.5586 article EN European Journal of Ophthalmology 2010-09-20

We report our findings in a patient who developed central retinal vein occlusion (CRVO) and was chronic user of olanzapine, an antipsychotic medication.A 50-year-old Caucasian man, non-smoker, referred to clinic with the chief complaint floater appearance his left eye for past 3 days. His medical history indicated that he had been taking drugs (olanzapine) about years, no other systemic disease or risk factors CRVO. In examination, best-corrected visual acuity (BCVA) 0.7 eye. The fundus...

10.1186/s13256-021-02865-8 article EN cc-by Journal of Medical Case Reports 2021-05-28
Coming Soon ...